Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study

[1]  B. Han,et al.  Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes. , 2011, World journal of gastroenterology.

[2]  Yitao Ding,et al.  No enhanced expression and infectivity of porcine endogenous retrovirus in primary porcine hepatocytes with chitosan nanofiber scaffold. , 2011, Journal of Biomedical Nanotechnology.

[3]  R. Chamuleau,et al.  Long‐term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell–based Academic Medical Center bioartificial liver , 2010, Xenotransplantation.

[4]  C. Legallais,et al.  Artificial and bioartificial liver devices: present and future , 2009, Gut.

[5]  Zhangqi Feng,et al.  In vitro evaluation of a multi-layer radial-flow bioreactor based on galactosylated chitosan nanofiber scaffolds. , 2009, Biomaterials.

[6]  Yitao Ding,et al.  Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro , 2009, Journal of cellular physiology.

[7]  Wilson Ca,et al.  Porcine endogenous retroviruses and xenotransplantation. , 2008 .

[8]  J. Gerlach,et al.  Bioartificial liver systems: why, what, whither? , 2008, Regenerative medicine.

[9]  S. Nyberg,et al.  Artificial and bioartificial liver support. , 2008, Seminars in liver disease.

[10]  S. Riordan,et al.  Perspectives on liver failure: past and future. , 2008, Seminars in liver disease.

[11]  William M. Lee,et al.  Acute liver failure: Summary of a workshop , 2007, Hepatology.

[12]  C. Wilson.  Porcine endogenous retroviruses and xenotransplantation. , 2008, Cellular and molecular life sciences : CMLS.

[13]  Y. Takeuchi,et al.  Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species , 2007, Retrovirology.

[14]  Yu-ming Wang,et al.  Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system. , 2006, World journal of gastroenterology.

[15]  R. Chamuleau,et al.  Which Are the Right Cells to be Used in a Bioartificial Liver? , 2005, Metabolic Brain Disease.

[16]  E. Dalakas,et al.  Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. , 2005, World journal of gastroenterology.

[17]  S. Cherqui,et al.  Pseudotyping of Porcine Endogenous Retrovirus by Xenotropic Murine Leukemia Virus in a Pig Islet Xenotransplantation Model , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Chamuleau,et al.  No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC‐bioartificial liver , 2005, Xenotransplantation.

[19]  Wei-Shou Hu,et al.  Characterization of a hollow fiber bioartificial liver device. , 2005, Artificial organs.

[20]  M. Hermida-Prieto,et al.  Lack of Cross-Species Transmission of Porcine Endogenous Retrovirus in Pig-to-Baboon Xenotransplantation with Sustained Depletion of Anti-&agr;Gal Antibodies , 2005, Transplantation.

[21]  M. Sykes,et al.  Mouse retrovirus mediates porcine endogenous retrovirus transmission into human cells in long-term human-porcine chimeric mice. , 2004, The Journal of clinical investigation.

[22]  Carolyn Wilson,et al.  Limited infection without evidence of replication by porcine endogenous retrovirus in guinea pigs. , 2004, The Journal of general virology.

[23]  R. Kurth,et al.  Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  I M Sauer,et al.  Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells , 2003, Xenotransplantation.

[25]  N. Kobayashi,et al.  Cell choice for bioartificial livers. , 2003, The Keio journal of medicine.

[26]  R. Chamuleau,et al.  Bridging a Patient with Acute Liver Failure to Liver Transplantation by the AMC-Bioartificial Liver , 2003, Cell transplantation.

[27]  S. Farhadian,et al.  Identification of receptors for pig endogenous retrovirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Martignat,et al.  Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice , 2002, Diabetologia.

[29]  G. Mazariegos,et al.  Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. , 2002, Transplantation.

[30]  P. Newsome,et al.  Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  A. Shepherd,et al.  Design and validation of immunological tests for the detection of Porcine endogenous retrovirus in biological materials. , 2000, Journal of virological methods.

[32]  W. Rawlinson,et al.  TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUSES IN SEVERE COMBINED IMMUNODEFICIENT MICE XENOTRANSPLANTED WITH FETAL PORCINE PANCREATIC CELLS1 , 2000, Transplantation.

[33]  B. Torbett,et al.  Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice , 2000, Nature.

[34]  H. Nitschko,et al.  A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation. , 2000, Transplantation.

[35]  R. Wiesner,et al.  Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  R. Wiesner,et al.  Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  C. Mullon,et al.  Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. , 1999, Artificial organs.

[38]  W. Heneine,et al.  Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. , 1999, Science.

[39]  W. Heneine,et al.  Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. , 1999, Transplantation.

[40]  D H Persing,et al.  Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. , 1999, Transplantation.

[41]  R. Weiss,et al.  Host range and interference studies of three classes of pig endogenous retrovirus. , 1999, Journal of virology.

[42]  W. Heneine,et al.  No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts , 1998, The Lancet.

[43]  R. Weiss,et al.  Two sets of human-tropic pig retrovirus , 1997, Nature.

[44]  Yasuhiro Takeuchi,et al.  Infection of human cells by an endogenous retrovirus of pigs , 1997, Nature Medicine.

[45]  J. Armstrong,et al.  C-type virus particles in pig kidney cell lines. , 1971, The Journal of general virology.